Establishment Labs Holdings Inc. (NASDAQ:ESTA) Shares Acquired by Northern Trust Corp

Northern Trust Corp grew its stake in Establishment Labs Holdings Inc. (NASDAQ:ESTA - Free Report) by 53.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 28,165 shares of the company's stock after buying an additional 9,865 shares during the quarter. Northern Trust Corp owned 0.10% of Establishment Labs worth $1,298,000 as of its most recent filing with the SEC.

Other hedge funds and other institutional investors have also made changes to their positions in the company. Capital Research Global Investors lifted its stake in Establishment Labs by 29.3% in the fourth quarter. Capital Research Global Investors now owns 1,911,525 shares of the company's stock worth $88,064,000 after acquiring an additional 433,484 shares during the last quarter. William Blair Investment Management LLC lifted its position in shares of Establishment Labs by 44.1% during the 4th quarter. William Blair Investment Management LLC now owns 812,825 shares of the company's stock worth $37,447,000 after purchasing an additional 248,888 shares during the last quarter. Boothbay Fund Management LLC grew its stake in shares of Establishment Labs by 68.8% during the fourth quarter. Boothbay Fund Management LLC now owns 525,248 shares of the company's stock worth $24,198,000 after purchasing an additional 214,119 shares in the last quarter. Voya Investment Management LLC grew its stake in shares of Establishment Labs by 7,249.5% during the fourth quarter. Voya Investment Management LLC now owns 408,262 shares of the company's stock worth $18,809,000 after purchasing an additional 402,707 shares in the last quarter. Finally, Portolan Capital Management LLC increased its holdings in Establishment Labs by 243.1% in the fourth quarter. Portolan Capital Management LLC now owns 193,991 shares of the company's stock valued at $8,937,000 after buying an additional 137,458 shares during the last quarter. Hedge funds and other institutional investors own 72.91% of the company's stock.

Establishment Labs Stock Performance

Shares of Establishment Labs stock traded down $1.21 during trading hours on Thursday, hitting $34.68. 461,601 shares of the company were exchanged, compared to its average volume of 474,163. Establishment Labs Holdings Inc. has a 1 year low of $26.56 and a 1 year high of $58.00. The stock has a market capitalization of $1.00 billion, a price-to-earnings ratio of -13.44 and a beta of 0.73. The company has a current ratio of 3.62, a quick ratio of 2.29 and a debt-to-equity ratio of 5.94. The business has a 50-day moving average of $34.01 and a 200-day moving average of $37.64.

Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its quarterly earnings results on Wednesday, May 7th. The company reported ($0.70) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.83) by $0.13. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. The firm had revenue of $41.38 million during the quarter, compared to analysts' expectations of $41.15 million. During the same period in the prior year, the company posted ($0.58) earnings per share. The firm's revenue for the quarter was up 11.3% on a year-over-year basis. As a group, analysts expect that Establishment Labs Holdings Inc. will post -2.41 EPS for the current fiscal year.

Wall Street Analyst Weigh In

ESTA has been the subject of several analyst reports. Stephens reaffirmed an "overweight" rating and set a $52.00 price objective on shares of Establishment Labs in a research report on Thursday, March 6th. Needham & Company LLC raised shares of Establishment Labs from a "hold" rating to a "buy" rating and set a $48.00 price objective on the stock in a report on Wednesday, May 14th. Wall Street Zen lowered shares of Establishment Labs from a "hold" rating to a "sell" rating in a research note on Thursday, May 22nd. Finally, BTIG Research started coverage on shares of Establishment Labs in a research report on Friday, May 16th. They issued a "buy" rating and a $62.00 price target for the company. One analyst has rated the stock with a sell rating, one has issued a hold rating and five have assigned a buy rating to the company's stock. Based on data from MarketBeat, the company has an average rating of "Moderate Buy" and an average price target of $55.33.

Establishment Labs Company Profile

Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.